Richard Staines presents a round-up of the week’s digital health news
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.
A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle men’.
Cutting-edge technologies are increasingly improving pharma’s R&D processes.
Novartis says it will scale up the use of Apple ResearchKit in clinical trials, as part of its efforts to bring about digital transformation.
February 12, 2018
Setting a New Standard for Optimizing Clinical Trials
